Phathom Pharmaceuticals Inc (PHAT)
Cost of Revenue
$40.93M
TTM · Period ending: · USD
PHAT Cost of Revenue
Latest reported$40.93Mperiod ending
Latest reported$40.93Mperiod ending
PHAT TTM Cost of Revenue ($0.00 → $40.93M)
TTM cost of revenue
High-resolution chart · PNG
PHAT cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 40,930,000 | |
| 30,872,000 | |
| 22,600,000 | |
| 18,767,000 | |
| 14,933,000 | |
| 11,271,000 | |
| 7,973,000 | |
| 4,510,000 | |
| 2,275,000 | |
| 1,022,000 | |
| 596,000 | |
| 412,000 | |
| 466,000 | |
| 492,000 | |
| 620,000 | |
| 587,000 | |
| 542,000 | |
| 524,000 | |
| 521,000 | |
| 386,000 | |
| 256,000 | |
| 125,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |